https://www.foxbusiness.com/economy/cdc-advisory-panel-recommends-pfizer-and-modern-vaccines-over-johnson-johnson - https://www.foxbusiness.com/economy/cdc-advisory-panel-recommends-pfizer-and-modern-vaccines-over-johnson-johnson

http://video.foxbusiness.com/v/6248831391001 - Blood clotting from Johnson & Johnson vaccine 'extremely rare': Dr. Nesheiwat

Dr. Janette Nesheiwat on Johnson & Johnson vaccine

An advisory panel to the CDC unanimously voted to give a preferential recommendation to mRNA https://www.foxbusiness.com/category/fox-news-vaccines - vaccines , like those made by Pfizer and Moderna, over the one-shot Johnson & Johnson vaccine due to rare but serious blood clots.

The CDC temporarily halted Johnson & Johnson’s vaccine in April while scientists investigated the blood clots, which are known as "thrombosis with thrombocytopenia syndrome."

Regulators eventually decided that the benefits of the Johnson & Johnson vaccine outweigh the risks, but the https://www.fda.gov/media/146304/download" rel="nofollow - FDA released new data this week showing that more cases have occurred in the summer and fall. 

https://www.foxbusiness.com/economy/supply-chain-issues-pharmacists-what-to-know - SUPPLY CHAIN ISSUES IMPACTING PHARMACIES: WHAT TO KNOW

Women between the ages of 30 anjd 49 are most affected by the blood clotting issue at a rate of about 1 in 100,000 shots. 

There have been nine deaths linked to the Johnson & Johnson vaccine through September. 

Liesl Eibschutz, a medical student from Dartmouth University, loads a syringe with Pfizer COVID-19 vaccine before giving it to people on the first day that people ages 16 and up can receive the vaccine at Kedren Health on Thursday, April 15, 2021 in 

https://www.foxbusiness.com/ - CLICK HERE TO READ MORE ON FOX BUSINESS

Only about 16 million doses of the Johnson & Johnson vaccine have been administered in the United States, compared to about 470 million doses of Pfizer and Moderna's vaccines. 

The recommendation now goes to CDC Director Rochelle Walensky for final approval.